Skip to main content
. 2021 Mar;9(5):417. doi: 10.21037/atm-21-761

Figure 2.

Figure 2

BCAAs were upregulated in clinical samples of PDAC. (A) workflow for the NMR process to detect metabolites in serum; (B) principal component analysis score plots showing differences in metabolic molecules between the PDAC patients and HCs; (C) the AUC was 0.9375, reflecting the accuracy of the results. (D,E,F) BCAA levels were significantly higher in PDAC patients compared to HCs in serum. (G,H,I) BCAA levels were significantly higher in PDAC patients compared to HCs in tissues. BCAAs, branched-chain amino acids; PDAC, pancreatic ductal adenocarcinoma; HC, healthy controls.